Resurgent Interest in Plant-Based Vaccines, Monoclonal Antibodies
نویسندگان
چکیده
منابع مشابه
Monoclonal Antibodies
SUMMARY Monoclonal Antibodies are identical antibodies and Can be generated in ultimated amounts by countinuos cultures of single antibody- secreting cells. These cell lines are produced by cell fusion of normal lymphocytes to cells of a myeloma tumor cell line, which confers on the antibody producing hybrid cell, immortality and the ability grow as atumor in animals. monoclonal antibodies c...
متن کاملMonoclonal Antibodies against Plant Viruses
It has been well established that monoclonal antibodies, since their initial description', play an important role on biological research . This technique has also been applied to studies on plant virus2·6> and this aspect was reviewed >. The basic characteristics of monoclonal antibodies are that (1) the antibody specifically reactive with one epitope can be obtained, (2) a hybridoma clone, onc...
متن کاملPlant biopharming of monoclonal antibodies.
Recent advances in molecular biology and plant biotechnology have shifted the concept of growing crops as a food source to serving as a bioreactor for the production of therapeutic recombinant proteins. Plants are potential biopharming factories because they are capable of producing unlimited numbers and amounts of recombinant proteins safely and inexpensively. In the last two decades, plant pr...
متن کاملThird International Conference on Plant-Based Vaccines and Antibodies.
This relatively new biennial meeting - the first was in Prague in 2005 - was chaired by Julian Ma (Guy's Hospital, London, UK), with Mario Pezzotti (University of Verona, Italy) as local organizer, and attracted approximately 180 delegates from 25 countries. The theme was 'Plant Expression Systems for Recombinant Pharmacologics': there were 46 talks gathered into two plenaries, 12 themed sessio...
متن کاملPalettes of vaccines and immunostimulatory monoclonal antibodies for combination.
Various monoclonal antibodies (mAb) target immune system molecules to enhance immunity by costimulating T cells (i.e., CD137, OX40, CD40, GITR) or interfering in coinhibitory signals (i.e., CTLA-4, PD-1). These powerful agents can be guided by cancer vaccines to enhance immunity against tumor but not self tissues. Clinically powerful therapeutic synergies are at hand.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Microbe Magazine
سال: 2014
ISSN: 1558-7452,1558-7460
DOI: 10.1128/microbe.9.228.2